| Literature DB >> 28828318 |
Wen Song1, Wenhui Teng2, Xinyan Shi3, Xiaozhen Liu4, Zheng Cui1, Zibin Tian5.
Abstract
BACKGROUND: The aim of this study was to explore the relationship between nutritional status and expression of RUNX3 in gastric cancer cells and to investigate the effects of nursing strategies on the nutritional status of elderly patients with advanced gastric cancer.Entities:
Keywords: Advanced gastric cancer; Holistic nursing; Nutritional status evaluation; RUNX3
Year: 2017 PMID: 28828318 PMCID: PMC5558069
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
PCR primers used in this study
| RUNX3 | Forward primer: 5′-TTATGAGGGGTGGTTGTATGTGGG-3′ |
| Reverse primer: 5′-AAACAACCAACACAAACACCTCC-3′ | |
| β-actin | Forward primer: 5′- GATGATTGGCATGGCTTT-3′ |
| Reverse primer: 5′- CACCTTCCGTTCCAGTTT-3′ |
Fig. 1:Detection of RUNX3 expression levels using semi-quantitative PCR. Compared with adjacent tissues of cancer and normal gastric tissues, the expression levels of RUNX3 gene in advanced gastric cancer tissues were significantly decreased (P<0.01)
Fig. 2:Detection of RUNX3 protein expression by using Western-blot. A: The results of expression detected by western blot. B: The relative expression levels of RUNX3. Compared with adjacent tissues of cancer and normal gastric tissues, the expression levels of RUNX3 protein in advanced gastric cancer tissues were significantly decreased, **P<0.01
Relationship between the relative expression of RUNX3 and clinical features of patients
| Gender | |||
| Male | 25 | 0.467±0.121 | 0.0863 |
| Female | 23 | 0.496±0.113 | |
| Age | |||
| > 70 years | 42 | 0.485±0.109 | 0.0792 |
| ≤ 70 years | 6 | 0.502±0.117 | |
| Tumor size (cm) | |||
| ≤ 5 | 35 | 0.787±0.114 | 0.0086 |
| > 5 | 13 | 0.426±0.103 | |
| Clinical staging | |||
| Stage I – II | 9 | 0.815±1.23 | 0.0079 |
| Stage III – IV | 39 | 0.328±1.17 | |
| Lymphatic metastasis | |||
| Yes | 41 | 0.281±0.122 | 0.0063 |
| No | 7 | 0.732±0.156 | |
| Recurrence | |||
| Yes | 32 | 0.359±1.52 | 0.0056 |
| No | 16 | 0.987±1.69 | |
Note: Expression of RUNX3 was significantly lower among the adverse classification of each clinical indicators, including tumor size, clinical staging, metastasis and recurrence (**P<0.05).
Relationship between nutritional status evaluation and RUNX3 expression in patients with advanced gastric cancer
| SGA-A | 5.7 | 38.5 | < 0.05 |
| SGA-B | 54.3 | 38.5 | |
| SGA-C | 40.0 | 23.0 | |
| TSF: normal | 8.5 | 46.2 | < 0.01 |
| TSF: mild - moderate malnutrition | 57.2 | 38.5 | |
| TSF: severe malnutrition | 34.3 | 15.3 | |
| PA - normal group | 5.7 | 61.5 | < 0.01 |
| PA - malnutrition group | 94.3 | 38.5 | |
| ALB - normal group | 8.5 | 69.2 | < 0.01 |
| ALB - malnutrition group | 91.5 | 30.8 |
Note: The results of the self-rating scale of SGA showed that the nutritional statuses of patients with low expressions of RUNX3 were significantly lower (*P<0.05). The results of TSF and serum prealbumin indicated that the nutritional statuses of patients with low expressions of RUNX3 were significantly lower (**P<0.01).
Evaluation of nutritional statuses of patients after holistic nursing
| SGA-A | 43.9 | 38.5 | > 0.05 |
| SGA-B | 34.6 | 38.5 | |
| SGA-C | 21.5 | 23.0 | |
| TSF: normal | 42.5 | 46.2 | > 0.05 |
| TSF: mild - moderate malnutrition | 37.2 | 38.5 | |
| TSF: severe malnutrition | 20.3 | 15.3 | |
| PA - normal group | 59.7 | 61.5 | > 0.05 |
| PA - malnutrition group | 40.3 | 38.5 | |
| ALB - normal group | 63.5 | 69.2 | > 0.05 |
| ALB - malnutrition group | 36.5 | 30.8 |
Note: The results of self-rating scale of SGA, TSF and serum prealbumin showed that the nutritional statuses of patients with low expression of RUNX3 after holistic nursing practices were equivalent to those of patients with normal or high expression of RUNX3 and who received routine nursing practices (P<0.05)
Fig. 3:Relationship between RUNX3 expression levels and the survival time of patients. The survival time of patients with low expressions of RUNX3 after receiving holistic nursing were equivalent to those of patients with normal or high expressions of RUNX3 after receiving routine nursing, showing no statistically significant differences (P>0.05)